|
|
Volumn 68, Issue 5, 2015, Pages 795-801
|
|
Long-term safety and antitumor activity in the phase 1-2 study of enzalutamide in pre- and post-docetaxel castration-resistant prostate cancer
a
|
|
Author keywords
Androgen receptor inhibitor; Castration resistant prostate cancer; Enzalutamide; Long term follow up; MDV3100; Tolerability
|
|
Indexed keywords
DOCETAXEL;
ENZALUTAMIDE;
KETOCONAZOLE;
PROSTATE SPECIFIC ANTIGEN;
ANDROGEN RECEPTOR ANTAGONIST;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
KALLIKREIN;
KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;
PHENYLTHIOHYDANTOIN;
TAXOID;
ADULT;
AGED;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ARTHRALGIA;
ARTICLE;
ASTHENIA;
BACKACHE;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER PATIENT;
CASTRATION RESISTANT PROSTATE CANCER;
CHEMOTHERAPY INDUCED ANEMIA;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
CONSTIPATION;
CONVULSION;
DIARRHEA;
DIZZINESS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FAINTNESS;
FATIGUE;
FOLLOW UP;
HUMAN;
LIMB PAIN;
LONG TERM EXPOSURE;
MAJOR CLINICAL STUDY;
MALE;
MAXIMUM TOLERATED DOSE;
PERIPHERAL EDEMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QT PROLONGATION;
SPINAL CORD COMPRESSION;
ANALOGS AND DERIVATIVES;
BLOOD;
BONE NEOPLASMS;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
LYMPH NODE;
MIDDLE AGED;
PATHOLOGY;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SECONDARY;
TUMOR RECURRENCE;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANDROGEN RECEPTOR ANTAGONISTS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BONE NEOPLASMS;
DISEASE-FREE SURVIVAL;
HUMANS;
KALLIKREINS;
LYMPH NODES;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PHENYLTHIOHYDANTOIN;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
TAXOIDS;
|
|
EID: 84942984668
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2015.01.026 Document Type: Article |
|
Times cited : (45)
|
|
References (7)
|
